Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
3 Top Dividend Stocks to Buy in February
12:52pm, Wednesday, 05'th Feb 2025
Dividend stocks are increasingly appealing for investors in 2025 due to their potential for steady income and resilience in volatile markets.
Should You Pick PFE Stock At $25?
11:18am, Wednesday, 05'th Feb 2025
Pfizer stock (NYSE: PFE) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $17.8 billion and adjusted earnings of $0.63 per s
MoneyShow's Best Investment Ideas For 2025: Part 9
10:35am, Wednesday, 05'th Feb 2025
MoneyShow presents top investment ideas for 2025 from their contributors. This year's edition presents a broad mix of theme-based stock picks, momentum-driven high-flyers and beaten-up stocks with tur
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Wednesday, 05'th Feb 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Pfizer, Inc. (PFE) Q4 2024 Earnings Call Transcript
03:43pm, Tuesday, 04'th Feb 2025
Pfizer, Inc. (NYSE:PFE ) Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ET Company Participants Francesca DeMartino - Senior Vice President, Chief Investor Relations Officer Albert Bourla
Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales
12:40pm, Tuesday, 04'th Feb 2025
PFE beats fourth-quarter estimates for earnings and sales. It maintains 2025 guidance.
Nasdaq Surges Over 1%; Pfizer Earnings Top Estimates
12:21pm, Tuesday, 04'th Feb 2025
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.
Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job
11:51am, Tuesday, 04'th Feb 2025
Shares of vaccine makers and packaged food companies fell on Tuesday after President Donald Trump's pick for U.S. health secretary, Robert F. Kennedy Jr., moved closer to the job after a favorable vot
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
11:50am, Tuesday, 04'th Feb 2025
Shares of vaccine companies fell after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services to the full chamber.
Pfizer's fourth quarter sales and earnings top expectations
11:26am, Tuesday, 04'th Feb 2025
Pfizer Inc (NYSE:PFE, ETR:PFE) posted stronger-than-expected financial results for the fourth quarter and reaffirmed its 2025 revenue guidance. The company continues to expect between $61 billion and
Compared to Estimates, Pfizer (PFE) Q4 Earnings: A Look at Key Metrics
10:37am, Tuesday, 04'th Feb 2025
The headline numbers for Pfizer (PFE) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
PFE's Colorectal Cancer Drug Meets Other Dual Primary Goal of PFS
10:30am, Tuesday, 04'th Feb 2025
Pfizer's late-stage BRAF V600E-mutant mCRC study of the Braftovi combo regimen meets its other dual primary endpoint of PFS with statistical significance.
2 Blue-Chip Drug Stocks in Focus Today After Earnings
10:06am, Tuesday, 04'th Feb 2025
Stocks are struggling for direction today, and one sector that represents this choppiness is blue-chip drugmakers.
Pfizer Beats Q4 Revenue, EPS Estimates
09:35am, Tuesday, 04'th Feb 2025
Pharmaceuticals giant Pfizer (PFE -0.21%) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. The company reported an adjusted earnings p
Pfizer (PFE) Beats Q4 Earnings and Revenue Estimates
09:00am, Tuesday, 04'th Feb 2025
Pfizer (PFE) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.10 per share a year ago.
